Valneva and Pfizer Report Further Positive Phase 2 Results, Including Booster Response, for Lyme Disease Vaccine Candidate

Published Date
Authors
VALNEVA

 

Saint-Herblain (France) and New York (United States)September 28, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE), today announced further positive Phase 2 results, including booster response, for Lyme disease vaccine candidate VLA15.

From: Valneva and Pfizer Report Further Positive Phase 2 Results, (globenewswire.com)